HDACs and Their Inhibitors on Post-Translational Modifications: The Regulation of Cardiovascular Disease
Cardiovascular diseases (CVD), such as myocardial hypertrophy, heart failure, atherosclerosis, and myocardial ischemia/reperfusion (I/R) injury, are among the major threats to human health worldwide. Post-translational modifications alter the function of proteins through dynamic chemical modificatio...
Saved in:
Main Authors: | Siyi Yang, Yidong Sun, Wei Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-07-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/14/14/1116 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design and synthesis of polymer nanoparticles with pH-responsive pan-HDAC inhibitor (C5) derived from norbornene block copolymers to increase C5 solubility and improve its targeted delivery to prostate cancer sites
by: Jacob Mathew, et al.
Published: (2025-12-01) -
Post-Translational Modification of p62: Roles and Regulations in Autophagy
by: Shuai Xiao, et al.
Published: (2025-07-01) -
Advances of HDAC inhibitors in tumor therapy: potential applications through immune modulation
by: Jiaqi Tian, et al.
Published: (2025-06-01) -
New trends and hotspots in sepsis-related protein post-translational modification: a bibliometric and visual analysis
by: Lin Song, et al.
Published: (2025-07-01) -
Enzyme-independent functions of HDAC3 in the adult heart
by: Sichong Qian, et al.
Published: (2025-07-01)